With the coming of a new year—and a new administration—there have been unsettling indications that some long-standing public health policies and evidence-based healthcare recommendations may be ...
Johnson & Johnson's (JNJ) fourth-quarter results topped market expectations while the healthcare products conglomerate anticipates results in 2025 to be higher than the previous year. The company sees ...
Results that may be inaccessible to you are currently showing.